The Worldwide Market for Point-of-Care (POC) Testing (Infectious Disease Testing, POC Cancer Tests, Rapid Coagulation, Urine Testing, Lipid Tests, Pregnancy Testing, Glucose Testing and Other POC)

    Published: February 16, 2018 | Price: $3,995.00 – $7,990.00

    What is the Size of the Point of Care Diagnostic Testing Market?   This report provides an in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations in the health arena is to provide expedited diagnosis where the patient is seen or in the patient’s home. The POC diagnostic industry will...
    What’s Trending in Monoclonal Antibodies (Market by Structure [Chimeric, Humanized], by Target [EGFR, TNF, HER2, CD20,PD-1, Other] and by Disease [Autoimmune, Oncology, Neurological, Other])

    Published: February 12, 2018 | Price: $4,500.00 – $9,000.00

    What's Trending in Monoclonal Antibodies (Markets by Structure, by Target, and by Indication) There are several types of monoclonal antibodies (mAbs) – large protein molecules produced by white blood cells (WBCs) that seek out and destroy harmful foreign substances – on the market and in development. What's Trending in Monoclonal Antibodies looks at the market for these, which are finding wide application in many areas of medicine and biologic science, by structure, by target, and by indication, including the following...
    The Market and Potential for CRISPR/Cas9 Gene Editing

    Published: February 5, 2018 | Price: $3,995.00 – $8,400.00

    The Market and Potential for CRISPR/Cas9 Gene Editing   This report consolidates the information and trends and provides reliable market estimates for CRISPR technology to 2023. As part of the report's coverage, it provides the following:   Market Size and Forecast for CRISPR/Cas9 Gene Editing, 2017-2023  The Market for CRISPR/Cas9 by Region (N. Amer. EU, ROW), 2017-2023 Analysis of Growth Trend by Region Market by Application (Cancer Research, Non-Cancer Disease Research, Cancer Diagnostics, Infection Diagnostics, Plant, Food, Biofuel, Drug Discovery, Drug Development,...
    The Market and Potential for Molecular Point of Care Diagnostic Tests

    Published: January 25, 2018 | Price: $3,995.00 – $7,900.00

    THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/   Among the various technologies and products of the global in vitro diagnostics (IVD) market, molecular diagnostics performed at the point of care or near the patient are regarded as a leading expansion market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics,...
    Global Over-the-Counter (OTC) Drug Markets

    Published: January 23, 2018 | Price: $3,995.00 – $7,990.00

    Global Over-the-Counter (OTC) Drug Markets Global Over-the-Counter (OTC) Drug Markets discusses the world and regional OTC markets, including information on the following: world OTC drug market revenues: 2017 to 2023; top twenty OTC drug markets, country market share (%), 2017 (United States, Japan, China, Germany, France, India, Brazil, Russia, United Kingdom, Australia, Mexico, Canada, Italy, Spain, Poland, Turkey, Argentina, Venezuela, South Africa, Saudi Arabia, rest of world); and world OTC drug market revenues, markets by product segment, 2017 to 2023...
    Direct-to-Consumer Testing Market

    Published: January 14, 2018 | Price: $4,500.00 – $9,000.00

    With advances in technology, the completion of the sequencing of the human genome and the pressures of capitalism, direct to consumer (DTC) laboratory testing is becoming increasingly popular. The growing market for DTC laboratory testing may promote awareness of health issues and genetic diseases, which could allow patients to take a more proactive role in their healthcare. The global DTC testing market is divided into two distinct areas of DTC testing: Routine clinical laboratory testing Medical genetic laboratory testing Kalorama’s...
    The Market for Direct-to-Consumer Genetic Health Testing

    Published: January 10, 2018 | Price: $4,200.00 – $7,990.00

    The Market for Direct-to-Consumer Genetic Health Testing The Market for Direct-to-Consumer Genetic Health Testing provides an overview of the laboratory testing industry for advanced genetic tests. Market trends covered include world DTC genetic testing revenues, 2017-2022; revenues and growth for the U.S. European, Asia Pacific, and rest of world DTC genetic testing market, 2017-2022; genetic testing market drivers and barriers; and global DTC genetic testing market analysis featuring genetic testing volume distribution for genetic testing services by order origination source...
    Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)

    Published: January 8, 2018 | Price: $2,995.00 – $5,990.00

    Tumor Markers Immunoassay Market (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others)Tumor Markers Immunoassay Market analyzes the current world market, including tumor markers immunoassay revenues by marker, 2015-2025 (PSA, CEA, CA 125, AFP, CA 15-3, CA 19-9, CYFRA 21-1, ProGRP, SCC, CA 72-4, HE4, Others, Total); regional revenues for tumor markers immunoassays, 2015-2025 (US, EU, ROW, Total); attributes of selected tumor marker immunoassays (cancer type, tissue analyzed, how used); and selected...
    European Medical Device Markets (Germany, France, United Kingdom, Italy, Spain, Switzerland, Sweden, Poland, Other Markets)

    Published: January 2, 2018 | Price: $3,995.00 – $7,990.00

    European Medical Device MarketsEuropean Medical Device Markets provides market size estimate and forecast to 2022 for the European market and individual country revenues, including Germany, France, UK, Italy, Spain, Sweden, Switzerland, and others; an examination of bellwether device companies; revenues for specific categories of medical devices; a look at market drivers and limiters; and competitive analysis of major device manufacturers.The report looks at the European device market and its trends, including medical device spending as a percentage of European health...
    Inherited Disease and Molecular Diagnostics Bundle 2017

    Published: December 20, 2017 | Price: $2,640.00 – $5,280.00

    Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer Markers
    Expected High Growth Market Segments in Molecular Diagnostic Testing

    Published: December 14, 2017 | Price: $2,000.00 – $4,000.00

    Expected High Growth Market Segments in Molecular Diagnostic Testing Tests for hepatitis, nucleic acid blood testing and respiratory testing are among the fast-growing segments of molecular testing in 2018, according to a new report from Kalorama Information.   will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report.  Average molecular IVD products will see six percent growth, the areas identified will be higher, over the next five years.   These are among the findings in...
    50 Key Biopharmaceutical and Biotechnology Companies

    Published: December 12, 2017 | Price: $2,000.00 – $4,000.00

    50 Key Biopharmaceutical and Biotechnology Companies Biopharmaceutical companies bring to market products that hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease. Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products. 50 Key Biopharmaceutical and Biotechnology Companies is a comprehensive look at the top 50 companies that are shaping the...
    Human Microbiome Applications in IVD and Other Healthcare

    Published: December 6, 2017 | Price: $1,200.00 – $2,400.00

    Human Microbiome Applications in IVD and Other Healthcare Human Microbiome Applications in IVD and Other Healthcare examines the growing interest in the human microbiome in in vitro diagnostics and other healthcare applications. This report notes IVD company interest in the microbiome, including selected microbiome-based tests, including selected molecular tests; microbiome-based diagnostic biomarkers; and precision or personalized medicine approaches to the microbiome. Human Microbiome Applications in IVD and Other Healthcare notes pharmaceutical company interest in the microbiome as well. Discussed are...
    Biopharmaceutical Contract Manufacturing (BCMO) Market – by Type of Service, by Organization and by Region

    Published: November 29, 2017 | Price: $3,600.00 – $7,200.00

    Estimating Market Size, Market Share, and Market Opportunity for Biopharmaceutical Contract Manufacturing Organizations    Over the past several years, an unprecedented number of blockbuster drugs have lost patent protection, and this trend is expected to continue through the foreseeable future. Yet pharmaceutical companies cannot always produce their needed pipeline in-house.  This has created an ideal market environment for biopharmaceutical contracting. This report, Biopharmaceutical Contract Manufacturing Market (BCMO) Market by Type of Service, by Organization and by Region, contains the following...
    Next-Generation Sequencing Trends: Kalorama Survey of Laboratories

    Published: November 21, 2017 | Price: $3,600.00 – $7,200.00

    Next-Generation Sequencing Trends: Kalorama Survey of Laboratories Next-Generation Sequencing Trends: Kalorama Survey of Laboratories identifies some of the key changes taking place with both next-generation sequencing (NGS) systems in relation to their usage in labs and in relation to the sequencing of clinical samples for diagnostic or clinical research purposes. The report surveys the following aspects of NGS systems: system installations; sequencer applications, clinical applications, and usage trends; preferences and evaluations; and future purchase plans. This survey – of 78...